George Kemble

George Kemble

Net worth: 616 637 $ as of 2026-10-30

65 year
Health Technology
Consumer Services

Profile

George W.
Kemble
is Executive Chairman at Sagimet Biosciences, Inc. since 2022.
Formerly, Dr. Kemble was Senior Vice President-Research & Development at MedImmune LLC from 2001 to 2011.
Other former roles include Director at LigoCyte Pharmaceuticals, Inc. and Staff Scientist at MedImmune Vaccines, Inc. Education includes a doctorate from Stanford University and an undergraduate degree from Santa Clara University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-08-13 62,161 ( 0.09% ) 616 637 $ 2026-10-30

George Kemble active positions

CompaniesPositionStart
SAGIMET BIOSCIENCES INC. Chairman 2022-10-23

Former positions of George Kemble

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 2010-12-31
Corporate Officer/Principal -
Director/Board Member -
See the detail of George Kemble's experience

Education of George Kemble

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

75

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology